Narrow search
Showing 1 - 10 of 53
Cover Image
Pricing and R&D with related margins
Geoffard, Pierre-Yves; Philipson, Tomas J. - 1998
Persistent link: https://www.econbiz.de/10000994774
Cover Image
Disease eradiction : private vs. public vaccination
Geoffard, Pierre-Yves; Philipson, Tomas J. - 1995
Persistent link: https://www.econbiz.de/10000908351
Cover Image
Data markets and optimal sample size determination
Geoffard, Pierre-Yves; Philipson, Tomas J. - 1998
Persistent link: https://www.econbiz.de/10000994775
Cover Image
Quantifying the value of personalized medicines : evidence from COX-2 inhibitors
Sood, Neeraj; Philipson, Tomas J.; Huckfeldt, Peter - In: Forum for health economics & policy : an evolving … 16 (2013) 1, pp. 101-122
Persistent link: https://www.econbiz.de/10010458340
Cover Image
Non-adherence in health care : a positive and normative analysis
Egan, Mark L.; Philipson, Tomas J. - 2014
Persistent link: https://www.econbiz.de/10010394647
Cover Image
International health economics
Egan, Mark L.; Philipson, Tomas J. - 2013
Persistent link: https://www.econbiz.de/10010434719
Cover Image
Is the Food and Drug Administration safe and effective?
Philipson, Tomas J.; Sun, Eric - 2007
Persistent link: https://www.econbiz.de/10010434768
Cover Image
Cost-benefit analysis of the FDA : the case of the Prescription Drug User Fee Acts
Philipson, Tomas J.; Berndt, Ernst R.; Gottschalk, … - 2007
Persistent link: https://www.econbiz.de/10010434769
Cover Image
The regulation of medical innovation and pharmaceutical markets
Philipson, Tomas J. - In: The journal of law & economics 45 (2002) 2,2, pp. 583-586
Persistent link: https://www.econbiz.de/10001780824
Cover Image
Assessing the impacts of the Prescription Drug User Fee Acts (PDUFA) on the FDA approval process
Berndt, Ernst R.; Gottschalk, Adrian H. B.; Philipson, … - 2004
Persistent link: https://www.econbiz.de/10002379705